Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most repr...
Main Authors: | Cron, Kyle R., Zhu, Kaya, Kushwaha, Deepa S., Hsieh, Grace, Merzon, Dmitry, Rameseder, Jonathan, Chen, Clark C., D'Andrea, Alan D., Kozono, David |
---|---|
Other Authors: | Massachusetts Institute of Technology. Computational and Systems Biology Program |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2013
|
Online Access: | http://hdl.handle.net/1721.1/81218 |
Similar Items
-
Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium Tuberculosis Proteasome
by: Totaro, Kyle A., et al.
Published: (2018) -
The development of doped radiosensitive glass
by: Bradley, D. A., et al.
Published: (2007) -
Substrate-guided optimization of the syringolins yields potent proteasome inhibitors with activity against leukemia cell lines
by: Totaro, Kyle A., et al.
Published: (2017) -
Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-kappaB activation.
by: Buchan, A, et al.
Published: (2000) -
Discovery of a "first-in-class" plant-derived cystine-stabilized proteasome inhibitor
by: Chan, Leonard Huang Yoon
Published: (2018)